JP2009517016A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517016A5
JP2009517016A5 JP2008541848A JP2008541848A JP2009517016A5 JP 2009517016 A5 JP2009517016 A5 JP 2009517016A5 JP 2008541848 A JP2008541848 A JP 2008541848A JP 2008541848 A JP2008541848 A JP 2008541848A JP 2009517016 A5 JP2009517016 A5 JP 2009517016A5
Authority
JP
Japan
Prior art keywords
purified
november
produced
accession number
under accession
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008541848A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517016A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/003967 external-priority patent/WO2007060550A2/en
Publication of JP2009517016A publication Critical patent/JP2009517016A/ja
Publication of JP2009517016A5 publication Critical patent/JP2009517016A5/ja
Withdrawn legal-status Critical Current

Links

JP2008541848A 2005-11-23 2006-11-23 組換え熱帯熱マラリア原虫（Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍ）メロゾイト表面タンパク質４および５およびこれらの使用 Withdrawn JP2009517016A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73997305P 2005-11-23 2005-11-23
PCT/IB2006/003967 WO2007060550A2 (en) 2005-11-23 2006-11-23 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012158992A Division JP2012254082A (ja) 2005-11-23 2012-07-17 組換え熱帯熱マラリア原虫（Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍ）メロゾイト表面タンパク質４および５およびこれらの使用

Publications (2)

Publication Number Publication Date
JP2009517016A JP2009517016A (ja) 2009-04-30
JP2009517016A5 true JP2009517016A5 (enExample) 2010-02-18

Family

ID=38067607

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008541848A Withdrawn JP2009517016A (ja) 2005-11-23 2006-11-23 組換え熱帯熱マラリア原虫（Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍ）メロゾイト表面タンパク質４および５およびこれらの使用
JP2012158992A Withdrawn JP2012254082A (ja) 2005-11-23 2012-07-17 組換え熱帯熱マラリア原虫（Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍ）メロゾイト表面タンパク質４および５およびこれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012158992A Withdrawn JP2012254082A (ja) 2005-11-23 2012-07-17 組換え熱帯熱マラリア原虫（Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍ）メロゾイト表面タンパク質４および５およびこれらの使用

Country Status (6)

Country Link
US (4) US8026354B2 (enExample)
EP (2) EP1954305B1 (enExample)
JP (2) JP2009517016A (enExample)
CN (1) CN101415436A (enExample)
CA (1) CA2630283A1 (enExample)
WO (1) WO2007060550A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030161840A1 (en) * 1992-10-19 2003-08-28 Institut Pasteur Plasmodium falciparum antigens inducing protective antibodies
US8026354B2 (en) * 2005-11-23 2011-09-27 Institut Pasteur Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
CN101671654B (zh) * 2009-10-13 2012-11-07 黑龙江八一农垦大学 抗边缘无浆体msp5蛋白的单克隆抗体及其应用
WO2011056216A1 (en) * 2009-11-05 2011-05-12 The United States Of America As Represented By The Secretary Of The Navy Plasmodium falciparum sporozoite and liver stage antigens
CU20100083A7 (es) * 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens
CN102533678A (zh) * 2012-01-10 2012-07-04 特菲(天津)生物医药科技有限公司 一种间日疟红内期疫苗及其制备方法
WO2015055772A1 (en) 2013-10-16 2015-04-23 Shirley Longacre Combination of plasmodium merozoite surface proteins msp4 and 1 and uses thereof
WO2015187652A1 (en) * 2014-06-02 2015-12-10 The Johns Hopkins University Malarial antigens derived from subtilisin-like protease 2 and vaccines and methods of use
US10622025B2 (en) 2018-06-05 2020-04-14 Seagate Technology Llc Carrierless storage chassis
US10354699B1 (en) 2018-06-05 2019-07-16 Seagate Technology Llc Carrierless storage chassis drive locking units
US11304328B2 (en) 2020-01-16 2022-04-12 Seagate Technology Llc Data storage retainer systems, methods, and devices

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
DE69034168T3 (de) 1989-03-21 2013-04-11 Vical, Inc. Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
FR2681786A1 (fr) 1991-09-27 1993-04-02 Centre Nat Rech Scient Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
FR2704145B1 (fr) 1993-04-21 1995-07-21 Pasteur Institut Vecteur particulaire et composition pharmaceutique le contenant.
DE69939327D1 (de) 1998-11-02 2008-09-25 Curis Inc Funktionelle antagonisten von hedgehog-aktivität
AU1818200A (en) * 1998-11-05 2000-05-22 Daniel Carucci Chromosome 2 sequence of the human malaria parasite (plasmodium falciparum) and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents
EP1267907A1 (en) * 2000-03-23 2003-01-02 Akzo Nobel N.V. Use of mia in immunotherapy
EP1529536A1 (en) * 2003-11-05 2005-05-11 Institut Pasteur Immunogenic composition having improved immunostimulation capacity
US20080260763A1 (en) * 2004-07-01 2008-10-23 The Regents Of The University Of California High Throughput Proteomics
US8026354B2 (en) * 2005-11-23 2011-09-27 Institut Pasteur Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use

Similar Documents

Publication Publication Date Title
JP2009517016A5 (enExample)
JP2007075118A5 (enExample)
NZ616992A (en) Anti-ilt7 antibody
HRP20211343T1 (hr) Protutijela protiv dkk-1
NL300911I2 (nl) sarilumab
NZ591855A (en) Novel immunotherapy against several tumors including neuronal and brain tumors
RU2015147300A (ru) Гуманизированные антитела к cxcr5, их производные и их применение
JP2006006329A5 (enExample)
JP2008511291A5 (enExample)
EA200870411A1 (ru) Полипептиды с усиленным противовоспалительным и пониженным цитотоксическим свойствами и связанные с ними способы
WO2007117577A3 (en) High affinity human antibodies to human il-18 receptor
NZ591541A (en) Pcsk9 antagonists
JP2004536568A5 (enExample)
RU2012108615A (ru) Трибология в сочетании с коррозионной стойкостью: новое семейство pvd-и pacvd-покрытий
JP2012507294A5 (enExample)
MX2010009889A (es) Cuerpo revestido con materiales duros.
GB2433936B (en) Therapeutic peptides
NO20090182L (no) A screen assembly for a vibratory separator
DK1377393T3 (da) Klæbefrie fluorpolymerbelægninger
JP2004531270A5 (enExample)
CU20080088A7 (es) Anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de calcitonina
MY155144A (en) NEW ANTIBODIES SPECIFIC OF THE ß-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS
WO2010057882A3 (de) Zusammensetzung zur herstellung von anti-amyloid beta-peptid-antikörpern mit d-peptiden
JP2007526891A5 (enExample)
WO2008021508A3 (en) Injection molding of ceramic elements